NCT02682745View on ClinicalTrials.gov

Single Dosing Clinical Trial of HL151

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 15, 2016

Primary Completion Date

February 12, 2016

Study Completion Date

February 12, 2016

Conditions
Rhinitis, Allergic, Perennial
Interventions
DRUG

HL151

Test drug l : HL151, 1T, single oral administration on an empty stomach, Test drug ll : HL151, 1T, single oral administration after meal

DRUG

TALION tab.

Reference drug: TALION tab, 1T, every 12 hours, oral administration

Trial Locations (1)

136-705

The Korea Univertisy Anam Hospital, Seoul

All Listed Sponsors
lead

Hanlim Pharm. Co., Ltd.

INDUSTRY

NCT02682745 - Single Dosing Clinical Trial of HL151 | Biotech Hunter | Biotech Hunter